Turning Point Therapeutics Inc (TP therapeutics) is a biopharmaceutical company that designs and develops clinical stage small molecule, targeted oncology therapies to address key limitations of existing lung cancer therapies
Turning Point Therapeutics Inc (TP therapeutics) is a biopharmaceutical company that designs and develops clinical stage small molecule, targeted oncology therapies to address key limitations of existing lung cancer therapies.
The top three firms on F4's Biotech & Life Sciences investor list.